Profile
Christian M.
Pangratz is currently Chief Executive Officer at Atriva Therapeutics GmbH since 2023 and Chief Executive Officer at Urteste SA starting in 2026.
Former positions include Chief Executive Officer & Director at Orikine Bio SL, Executive Director-Business Development at Nektar Therapeutics, Managing Director at sterna biologicals GmbH, Executive Vice President-Business Development at SkyePharma Plc, Principal at Bayer AG, Chief Business Officer at Vectura GmbH from 2013 to 2014, Principal at Pfizer GmbH, and Principal at Vienna GmbH.
Education includes undergraduate and graduate degrees from Webster University.
Christian Pangratz active positions
| Companies | Position | Start |
|---|---|---|
| URTESTE S.A. | Chief Executive Officer | 2026-08-31 |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Chief Executive Officer | 2023-01-14 |
Former positions of Christian Pangratz
| Companies | Position | End |
|---|---|---|
Orikine Bio SL
Orikine Bio SL BiotechnologyHealth Technology Operates as biotech company the develops cytokine based therapies to treat autoimmune, inflammatory and other immune mediated diseases | Chief Executive Officer | 2026-09-07 |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Corporate Officer/Principal | 2014-08-31 |
sterna biologicals GmbH
sterna biologicals GmbH Pharmaceuticals: MajorHealth Technology Produces pharmaceuticals for asthma and chronic diseases | Chief Executive Officer | - |
| SKYEPHARMA PLC | Corporate Officer/Principal | - |
Vienna GmbH
Vienna GmbH Financial ConglomeratesFinance Operates as an investment firm | Corporate Officer/Principal | - |
Training of Christian Pangratz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
SkyePharma Plc
SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products | Health Technology |
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Webster University
Webster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
Pfizer GmbH | |
Vienna GmbH
Vienna GmbH Financial ConglomeratesFinance Operates as an investment firm | Finance |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Health Technology |
sterna biologicals GmbH
sterna biologicals GmbH Pharmaceuticals: MajorHealth Technology Produces pharmaceuticals for asthma and chronic diseases | Health Technology |
Urteste SA
Urteste SA Medical SpecialtiesHealth Technology Develops diagnostic tests for most common cancers | Health Technology |
Orikine Bio SL
Orikine Bio SL BiotechnologyHealth Technology Operates as biotech company the develops cytokine based therapies to treat autoimmune, inflammatory and other immune mediated diseases | Health Technology |
- Stock Market
- Insiders
- Christian Pangratz
















